Asthma Australia Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Sydney, NSW Australia
Total Funding:N/A
Industry:Health
Founded:1992
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Asthma Australia's estimated annual revenue is currently $14M per year.
  • Asthma Australia's estimated revenue per employee is $270,000

Employee Data

  • Asthma Australia has 52 Employees.
  • Asthma Australia grew their employee count by 37% last year.
  • Asthma Australia currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$68.3M253N/AN/A-N/A
#2
$11.3M425%N/A-N/A
#3
$33.2M123N/AN/A-N/A
#4
$72.9M2707%N/A-N/A
#5
$29.2M1086%N/A-N/A
#6
$59.4M220N/AN/A-N/A
#7
$20.3M7527%N/A-N/A
#8
$22.4M838%N/A-N/A
#9
$241.7M895N/AN/A-N/A
#10
$13M48-6%N/A-N/A
Missing a competitor? Contribute!?
Submit

2.5 million Australians have asthma. Over 400 Australians die each year from asthma. Asthma Australia is the recognised national community voice of Australians with asthma and linked conditions and their carers.

keywords:N/A

52

Number of Employees

$14M

Revenue (est)

1

Current Jobs

37%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Asthma Australia News

09/06/2019 - PPG TAUBMANSEndure Interior Paint a Preferred Choice of ...

The National Asthma Council Australia's Sensitive Choice program named TAUBMANSEndure interior paint a preferred choice for interior ...

09/03/2019 - Asthma awareness week

It's Asthma Week (1-7 September), and Asthma Australia is here to help Australians with asthma and hay fever through pollen season. We've ...

09/01/2019 - National Asthma Week 2019

t's Asthma Week (1-7 September), and Asthma Australia is here to help Australians with asthma and hay fever through pollen season. We've ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$8.9M5227%N/A-N/A
#2
$10.9M5221%N/A-N/A
#3
$13M5273%N/A-N/A
#4
$9.4M5227%N/A-N/A
#5
$15.1M52550%N/A-N/A